comparemela.com

Latest Breaking News On - Salimetrics chief scientific - Page 1 : comparemela.com

Salimetrics Reveals New Circadian Phase Assessments for At-Home Sleep and Circadian Rhythm Testing

Salivary DLMO Assessment Kit from Salimetrics: Clinical Utility from Easy At-Home or In-Clinic Sample Collections for Sleep Patients

Salimetrics Expands Laboratory CLIA Certification for Saliva Testing

Salimetrics Launches Saliva Testing with Industry-Leading SARS-CoV-2 IgG Antibody Multiplex Assay Used in Vaccine Clinical Trials

Salimetrics Launches Saliva Testing with Industry-Leading SARS-CoV-2 IgG Antibody Multiplex Assay Used in Vaccine Clinical Trials Share Article Salimetrics now offers multiplex testing for antibodies against SARS-CoV-2 Nucleocapsid, Spike 1, and Spike 1 Receptor Binding Domain (RBD) using a single, easy-to-collect saliva sample. Researchers now have unparalleled access to saliva collection devices and COVID-19 antibody saliva testing on a robust and validated platform. This effort provides an unparalleled opportunity to reliably test saliva samples for antibodies to a combination of three SARS-CoV-2 antigens (Spike, N, RBD) in the same, easy to collect sample. CARLSBAD, Calif. (PRWEB) March 16, 2021 The Salimetrics SalivaLab R&D Testing facility has recently adapted and completed a fit-for-purpose validation of the industry-leading multiplex for the detection of IgG antibodies to SARS-CoV-2 Nucleocapsid, Spike 1

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.